Cannell Capital - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 71 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
Cannell Capital ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q1 2023$30,976
-3.2%
16,8350.0%0.01%0.0%
Q4 2022$31,987
-11.1%
16,8350.0%0.01%
-25.0%
Q3 2022$36,000
+227.3%
16,835
+320.8%
0.01%
+300.0%
Q2 2022$11,0004,0010.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 21,346,829$49,738,11274.10%
TFG Asset Management GP Ltd 12,000,000$27,960,0005.10%
Paradigm Biocapital Advisors LP 14,406,782$33,567,8022.28%
Lynx1 Capital Management LP 1,363,025$3,175,8482.10%
Deep Track Capital, LP 15,000,000$34,950,0001.35%
Affinity Asset Advisors, LLC 1,992,466$4,642,4461.31%
DAFNA Capital Management LLC 928,253$2,162,8290.67%
Frazier Life Sciences Management, L.P. 3,746,857$8,730,1770.58%
ARMISTICE CAPITAL, LLC 6,900,000$16,077,0000.25%
Blackstone Inc. 20,485,611$47,731,4740.20%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders